Omega-3 ethyl ester concentrate decreases total apolipoprotein CIII and increases antithrombin III in postmyocardial infarction patients

Clinical Drug Investigation

Volumn 15, Issue 6, 1998, Pages 473-482

  Swahn, Eva ^a   Von Schenck, Henning ^a   Olsson, Anders G ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; APOLIPOPROTEIN C3; FISH OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031809328     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199815060-00003     Document Type: Article

References (20)

1. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902
2. Wilson RF, Holida MD, While CW. Quantilatne angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 1986; 73: 286-93
3. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992; 70: 733-7
4. Hamsten A, Wiman B, de Faire U, et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Fngl J Med 1985; 313: 1558-63
5. Chivot L, Mainard F, Bigot E, et al. Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E. Atherosclerosis 1990; 82: 205-11
6. Recommendations of the European Atherosclerosis Society prepared by the international task force for prevention of coronary heart disease. Prevention of coronary heart disease: Scientific background and new clinical guidelines. Nutr Metabol Cardiovasc Dis 1992; 2: 113-56
7. Israel DH, Gorlin R, Fish oils in the prevention of atherosclerosis. J Am Coll Cardiol 1992; 19: 174-85
8. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989; 30: 785-807
9. Mehta J, Lawson D, Saldeen T. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J 1988; 116: 1201-6
10. Möller JM, Svaneborg N, Lervang H-H, et al. The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis. Thromb Res 1992; 67: 569-77
11. Mölgaard J, von Schenck H, Olsson AG. Effect simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Eur Heart J 1988; 9: 541-51
12. 3 lipid levels in coronary artery disease. Atherosclerosis 1985; 59: 131-6
13. Kane JW, Gowland G. A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Ann Clin Biochem 1986; 23: 509-13
14. Declerck PJ, Alessi MC, Verstreken M. et al. Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-5
15. Phillipson BE, Rothrock DW, Connor WE, et al. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985; 312: 1210-6
16. Davidson MH, Burns JH, Subbaiah PV, et al. Marine oil capsule therapy for the treatment of hyperlipidaemia. Arch Intern Med 1991; 151: 1732-40
17. Nestel PJ, Connor WE, Reardon MR, et al. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984; 74: 72-89
18. Wang C-S, McConathy WC, Kloer HU, et al. Modulation of lipoprotein lipase activity by apolipoproteins. Fffects of apolipoprotein C-III. J Clin Invest 1985; 75: 384-90
19. Blankenhorn DH, Alaupovic P, Wickham E, et al. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: lipid and non-lipid factors. Circulation 1990; 81: 470-6
20. Boberg M, Pollare T, Siegbahn A, et al. Supplementation with n-3-fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1992; 22: 645-50